SCHEMBL19919061

SCHEMBL19919061

CCc1cccc(Oc2nc(Nc3cc(Cl)c(C(=O)NC4CCNCC4)cc3OC)ncc2C(F)(F)F)c1C(=O)NC

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19919007 0.92 PTK2 (0.57) PTK2
SCHEMBL19919018 0.89 PTK2 (0.66) PTK2
SCHEMBL19918774 0.87 PTK2 (0.59) PTK2
SCHEMBL19918934 0.85 PTK2 (0.58) PTK2
SCHEMBL19918981 0.83 PTK2 (0.70) PTK2
SCHEMBL19918892 0.83 PTK2 (0.56) PTK2
SCHEMBL19918855 0.82 PTK2 (0.88) PTK2
SCHEMBL18949816 0.82 PTK2 (0.72) PTK2
SCHEMBL19918938 0.82 PTK2 (0.55) PTK2
SCHEMBL19918916 0.81 PTK2 (0.77) PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2367800-B1 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER BOEHRINGER INGELHEIM INT (DE) 2018-02-28 — — EP disclosed
Send feedback